Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB
journal of antimicrobial chemotherapy2016Vol. 71pp. 333-338
167
katarina2016journalsusceptibility
Abstract
AbstractObjectives. Fluoroquinolones (FQs) are important in the treatment of MDR-TB and in the definition of XDR-TB. Our objective was to investigate how discre